posted on Mar 21 by MedPage Today OB/Gyn in the Uncategorized category
SAN FRANCISCO (MedPage Today) -- A presurgical assay predicted ovarian cancer and metastases with greater than 90% sensitivity and cancer stage with almost 100% sensitivity, according to a study reported here.